Private Equity Deal Spotlight | Weekly Update

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.

Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.

• FFL Partners announced an investment in Apex Infusion. Headquartered in Signal Hill, California, Apex Infusion is a fast-growing provider of ambulatory infusion therapy services including intravenous immunoglobulin, specialty infusion, total parental nutrition and other therapeutic services. The investment aims to accelerate the growth of Apex Infusion, which currently operates 11 locations throughout California. FFL Partners is a PE firm based in San Francisco, focused on growth investments in health care and technology-enabled services, and currently has over $5B of cumulative capital commitments.
• Pamlico Capital sold its remaining equity stake in Digitech, a leading provider of revenue cycle management solutions for emergency medical services professionals, to its joint venture partner Sarnova. Sarnova is a national specialty distributor of health care products and services for the emergency medical services and acute care markets. Pamlico Capital is a Charlotte, North Carolina-based PE firm that invests in its target industries of communications, health care information technology, information services and technology-enabled services and software.
• Advanced MedAesthetic Partners recently announced a partnership with Curate MedAesthetics, a leading medical spa based in Chattanooga, Tennessee. This partnership is consistent with Advanced MedAesthetic Partners’ strategy to invest in practices that prioritize patient outcomes and offer exceptional clinical training and education. Advanced MedAesthetic Partners is a subsidiary of Leon Capital Group, a family-holding company that operates assets in the financial services, health care, real estate and technology industries.
• Premier Biotech, a toxicology testing solutions provider backed by Align Capital Partners, announced the acquisition of Desert Tox, LLC. Desert Tox is a provider of Substance Abuse and Mental Health Services Administration-certified laboratory testing services. The acquisition solidifies Premier Biotech as a full-service provider of oral- and urine-based toxicology testing services. This transaction also marks Premier Biotech’s first acquisition since Align Capital Partners acquired the company in November 2022. Align Capital Partners is a PE firm that invests in lower-middle market companies within sectors such as business services, technology, specialty manufacturing and distribution.
• Med-Metrix, a provider of technology-enabled, revenue cycle management solutions backed by A&M Capital Partners, announced the acquisition of Hospital Billing and Collection Service (“HBCS”). HBCS is a revenue cycle management company that offers revenue cycle improvements by streamlining processes and leveraging technology. The deal is expected to bolster Med-Metrix’s revenue cycle management offerings with HBCS’s advanced patient financial engagement and insurance reimbursement solutions. A&M Capital Partners is a PE investment firm that focuses on middle-market control transactions in North America.